Clinical Trial Update: Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 trial assessing ficlatuzumab with cisplatin and IMRT in locally advanced head and neck squamous cell carcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Ficlatuzumab (ficlatuzumab)

Snippet

Sponsor: Julie E. Bauman, MD, MPH | Conditions: Carcinoma, Squamous Cell of Head and Neck | Phase 1 | Status: TERMINATED